The 43 references in paper I. Vizel' Yu., A. Vizel' A., И. Визель Ю., А. Визель А. (2015) “Обзор материалов по саркоидозу, представленных на Конгрессе Европейского респираторного общества 2014 года // A review of data on sarcoidosis presented in the European Respiratory Society Congress 2014” / spz:neicon:pulmonology:y:2014:i:5:p:123-128

1
Puscinska E., Nowinski A., Goljan-Geremek A. et al. Mortality in sarcoidosis, results from one centre, long term observational study. Eur. Respir. J. 2014; 44 (Suppl. 58): 468.
(check this in PDF content)
2
Sobiecka M., Bartosiewicz M., Lewandowska K. et al. Sarcoidosis related to interferon and ribavirin treatment of hepatitis C. Analysis of four cases. Eur. Respir. J. 2014; 44 (Suppl. 58): 467.
(check this in PDF content)
3
Catinon M., Chemarin C., Villard E. et al. Sarcoidosis and pulmonary dust: Mineralogical analysis (MA) and optical microscopy (OM). Eur. Respir. J. 2014; 44 (Suppl. 58): 472.
(check this in PDF content)
4
Papakosta D., Spyropoulos G., Domvri K. et al. Long term follow-up of Greek patients with pulmonary sarcoidosis. Relation to transforming growth factor-beta genetic profile. Eur. Respir. J. 2014; 44 (Suppl. 58): 784.
(check this in PDF content)
5
Peletidou S., Zifa E., Grammatikopoulos A., Malli F. et al. Mitochondrial tRNA gene mutations in patients with idiopathic pulmonary fibrosis (IPF) and sarcoidosis.Eur. Respir. J. 2014; 44 (Suppl. 58): 824.
(check this in PDF content)
6
Calender A., Pacheco Y., Lebecque S. et al. Comparative phenotype and BTNL2 polymorphism in familial and sporadic sarcoidosis in the French SARCFAM cohort. Eur. Respir. J. 2014; 44 (Suppl. 58): 1734.
(check this in PDF content)
7
Milman N., Van Overeem Hansen T., Skov Jensen M. Does the BTNL2 genotype influence the course of disease in Danish sarcoidosis patients? Eur. Respir. J. 2014; 44 (Suppl. 58): 3224.
(check this in PDF content)
8
Navratilova Z., Novosadova E., Krsjakova T. et al. Differential bronchoalveolar expression of candidate microRNAs in chronic obstructive pulmonary disease, asthma bronchiale and pulmonary. Eur. Respir. J. 2014; 44 (Suppl. 58): 198.
(check this in PDF content)
9
Kishore A., Navratilova Z., Kolek V., Petrek M. Detection of exosomal miRNA in pulmonary sarcoidosis. Eur. Respir. J. 2014; 44 (Suppl. 58): 199.
(check this in PDF content)
10
Harlander M., Zupancic M., Salobir B., Tercelj M. Biomarkers in sarcoidois follow-up: Angiotensin-converting enzyme or chitotriosidase?Eur. Respir. J. 2014; 44 (Suppl. 58): 462.
(check this in PDF content)
11
Vucinic-Mihailovic V., Sumarac Z., Jovanovic D. et al. Assessing sarcoidosis activity: Is serum chitotriosidase a reliable marker? Study of 430 patients and 264 healthy controls. Eur. Respir. J. 2014; 44 (Suppl. 58): 1735.
(check this in PDF content)
12
Doubkova M., Karpisek M., Mazoch J. et al. Prognostic significance of selected biomarkers in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease. Eur. Respir. J. 2014; 44 (Suppl. 58): 471.
(check this in PDF content)
13
Bargagli E., Landi C., Carleo A. et al. Proteomic investigation of pulmonary sarcoidosis. Eur. Respir. J. 2014; 44 (Suppl. 58): 3878.
(check this in PDF content)
14
Lyamina S., Demyanenko N., Shelukhina S. et al. Functional phenotype of immune response and alveolar macrophages phenotype in pulmonary sarcoidosis. Eur. Respir. J. 2014; 44 (Suppl. 58): 1476.
(check this in PDF content)
15
Osinska I., Wolosz D., Urbankowski T., Domagala-Kulawik J. LSC 2014 abstract – M1/M2 subpopulations of macrophages in patients with sarcoidosis- influence of smoking status. Eur. Respir. J. 2014; 44 (Suppl. 58): 1733.
(check this in PDF content)
16
Dubaniewicz A. Heat shock proteins as 'danger signals' in sarcoidosis. Eur. Respir. J. 2014; 44 (Suppl. 58): 3790.
(check this in PDF content)
17
Roussou A., Papaioannou A., Manali E.et al. Serum levels of sestrin 2 in patients with sarcoidosis. Eur. Respir. J. 2014; 44 (Suppl. 58): 3797.
(check this in PDF content)
18
Chandrashekariah S., Rosha D. Sarcoidosis in India: Investigation into vitamin D and calcium metabolism. Eur. Respir. J. 2014; 44 (Suppl. 58): 3777.
(check this in PDF content)
19
Kouranos V., Tzelepis G., Rapti A. et al. Diagnosis of cardiac sarcoidosis: A crossectional study in 327 consecutive patients. Eur. Respir. J. 2014; 44 (Suppl. 58): 463.
(check this in PDF content)
20
Tosun M., Keskin S., Akilli H. et al. Determination of cardiac involvement of sarcoidosis with cardiac MR, ECHO and Holter ECG. Eur. Respir. J. 2014; 44 (Suppl. 58): 470.
(check this in PDF content)
21
Stanton K., Ganigara M., Corte T. et al. The utility of cardiac magnetic resonance imaging in the diagnosis of cardiac sarcoidosis.Eur. Respir. J. 2014; 44 (Suppl. 58): 1728.
(check this in PDF content)
22
Kouranos V., Rapti A., Peros E. et al. Predictors of cardiovascular events in newly diagnosed patients with sarcoidosis. Eur. Respir. J. 2014; 44 (Suppl. 58): 474.
(check this in PDF content)
23
Papiris S., Georgakopoulos A., Pianou N. et al 18F-FDGPET/CT for the evaluation of sarcoidosis patients. Eur. Respir. J. 2014; 44 (Suppl. 58): 657.
(check this in PDF content)
24
Dal Farra S., Picchio M., Incerti E. et al. Fluorine-18-fluorodeoxyglucose positron emission tomography (18F-FDGPET) may be useful in the management of sarcoidosis.Eur. Respir. J. 2014; 44 (Suppl. 58): 3222.
(check this in PDF content)
25
Menon B., Dogra V., Nima G. et al. Evaluation of thoracic HRCT findings in sarcoidosis. Eur. Respir. J. 2014; 44 (Suppl. 58): 664.
(check this in PDF content)
26
Hirche T.O., Hirche H., Cui X.W. et al. Ultrasound evaluation of mediastinal lymphadenopathy in patients with sarcoidosis. Eur. Respir. J. 2014; 44 (Suppl. 58): 671.
(check this in PDF content)
27
Marshall A., Ahmed L., Chalmers G. Experience of endobronchial ultrasound – transbronchial needle aspiration (EBUS-TBNA) in granulomatous disease.Eur. Respir. J. 2014; 44 (Suppl. 58): 469.
(check this in PDF content)
28
Kameneva M., Syrtsova D., Baranova O.et al. A. Changes in lung mechanics and gas exchange in patients with pulmonary sarcoidosis (PS). Eur. Respir. J. 2014; 44 (Suppl. 58): 4271.
(check this in PDF content)
29
Karagiannis K., Bikov A., Bonifazi M. et al. Impulse oscillometry measurements are correlated to quality of life in patients with pulmonary sarcoidosis. Eur. Respir. J. 2014; 44 (Suppl. 58): 740.
(check this in PDF content)
30
Boros P., Martusewicz-Boros M., Wesolowski S. Impact of smoking habit on lung function in a large cohort sarcoidosis patients. Eur. Respir. J. 2014; 44 (Suppl. 58): 475.
(check this in PDF content)
31
Karadalli M.N., Bosnak Guclu M., Camcioglu B. et al. Clinical determinants and chronotrophic responses of maximal exercise capacity in patients with early stage of sarcoidosis. Eur. Respir. J. 2014; 44 (Suppl. 58): 2158.
(check this in PDF content)
32
Laushkina Z. The analysis of factors associated with misdiagnosis sarcoidosis in TB hospital. Eur. Respir. J. 2014; 44 (Suppl. 58): 2676.
(check this in PDF content)
33
Nowinski A., Puscinska E., Goljan-Geremek A. et al. Comorbidities associated with sarcoidosis – Results from long-term observational study.Eur. Respir. J. 2014; 44 (Suppl. 58): 461.
(check this in PDF content)
34
Nathan N., Marcelo P., Houdouin V. et al. Is pulmonary sarcoidosis more severe in children? A multicentric retrospective study. Eur. Respir. J. 2014; 44 (Suppl. 58): 465.
(check this in PDF content)
35
Güungör S., Yalçinsoy M., Usta Bülbül E. et al. Extrapulmonary involvement in sarcoidosis patients.Eur. Respir. J. 2014; 44 (Suppl. 58): 3751.
(check this in PDF content)
36
Romanov V. Atypical variants of clinical course of sarcoidosis.Eur. Respir. J. 2014; 44 (Suppl. 58): 3782.
(check this in PDF content)
37
Baranova O., Perlei V., Gichkin A. et al. Pulmonary embolism (PE) in patients with pulmonary sarcoidosis (PS). Eur. Respir. J. 2014; 44 (Suppl. 58): 4508.
(check this in PDF content)
38
Omcikus M., Vucinic V., Filipovic S., Videnovic J. Cognitive failure in sarcoidosis. Eur. Respir. J. 2014; 44 (Suppl. 58): 460.
(check this in PDF content)
39
Martusewicz-Boros M., Boros P., Wiatr E., RoszkowskiSliz K. How many patients require corticosteroid treatment in sarcoidosis? – Preliminary study. Eur. Respir. J. 2014; 44 (Suppl. 58): 464.
(check this in PDF content)
40
Grah C., Thieme C., Seiberth R. et al. Benefit of steroidfree treatment compared to standard therapy (ST) in pulmonary sarcoidosis.Eur. Respir. J. 2014; 44 (Suppl. 58): 3765.
(check this in PDF content)
41
Goljan Geremek A., Bednarek M., Puscinska E. et al. Methotrexate (MTX) as a single agent for treating chronic, progressive sarcoidosis. Eur. Respir. J. 2014; 44 (Suppl. 58): 473.
(check this in PDF content)
42
Baranova O., Voinov V., Baklanova O. 30 years experience of plasmapheresis using in complex treatment of pulmonary sarcoidosis (PS). Eur. Respir. J. 2014; 44 (Suppl. 58): 4510.
(check this in PDF content)
43
Hostettler K., Baty F., Kleiner R. et al. Bosentan does not improve outcome in patients with steroid-resistant pulmonary sarcoidosis – Results from a double-blind placebocontrolled phase 2 trial.Eur. Respir. J. 2014; 44 (Suppl. 58): 466.
(check this in PDF content)